Illumina Inc
F:ILU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Illumina Inc
F:ILU
|
US |
|
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
TH |
|
G
|
Golden Cross Resources Ltd
F:GCL
|
AU |
|
K
|
K&K Superstore Southern PCL
SET:KK
|
TH |
|
S
|
Scor SE
DUS:SDRC
|
FR |
Intrinsic Value
Is ILU undervalued or overvalued?
See the intrinsic value estimate for 
Illumina Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ILU looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ILU’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Illumina Does
Illumina makes DNA sequencing systems and the consumables that run on them. Its machines read genetic code, and its test kits and reagents are used to prepare samples and generate sequencing data. The company mainly sells to hospitals, research labs, biotech companies, and clinical testing groups that need to analyze DNA for science or diagnosis.
- Headquarters
- United States of America US
- Employees
- 8 600
- IPO date
- Jun 28, 2000
Illumina has a narrow economic moat
Replacing Illumina equipment can mean rebuilding laboratory routines, retraining staff and checking that tests still produce reliable results, making a cheaper rival costly to adopt. Patents also prevent competitors from directly copying protected parts of its sequencing technology. These barriers help protect repeat purchases of supplies, rather than keeping competing systems out entirely.
Read the full moat analysis
Revenue & Expenses Breakdown
Illumina Inc
Earnings Waterfall
Illumina Inc
The intrinsic value for Illumina Inc (ILU) under the Base Case is hidden EUR.
Compared with the current market price of 240.05 EUR, the stock appears hidden.